DOSE-70
Brief description of study
3 OBJECTIVES AND ENDPOINTS
Primary and secondary outcomes will be assessed using routinely collected electronic health record data at Penn Medicine Princeton Medical Center, Pennsylvania Hospital, and Penn Medicine Lancaster General Hospital.
Exploratory outcomes will be assessed among those consenting to correlative analyses using additional data collected from participant step count monitoring, radiology studies, and questionnaires. Primary outcome: The proportion of eligible patients with a completed geriatric assessment within 30 days of initial oncology visit. Secondary outcome: The proportion of patients with geriatric impairment whose initial cycle of systemic therapy is dose modified.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
